← Back to all trials
Completed
NCT04157166
Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT(Cadmium-Zinc-Telluride) "VERITON-CT ™" Camera
Conditions: Bone Metastases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 146
Sponsor: Central Hospital, Nancy, France
Location: Service de Médecine Nucléaire - CHRU de Nancy-Brabois Vandœuvre-lès-Nancy
Summary
The purpose of the OSS study is to evaluate a procedure involving a single full body SPECT/CT (Single photon emission computed tomography coupled with a computerized tomography) 3D recording with a new semiconductor camera,his name is VERITON-CT ™ (Spectrum Dynamics Medical). This recording can be done in less than 25 minutes due to an original system of CZT (Cadmium-Zinc-Telluride) detectors allowing to increase the quality of the images and especially, to multiply by a factor 2 to 3 the detection sensitivity. This camera is also equipped with a scanner capable of obtaining a body-to-integer recording with a low level of irradiation (≤ 2 mSv)
Eligibility Criteria
Inclusion Criteria:
* Patient having read and understood the information document and having signed the consent.
* Patient referred for bone scintigraphy to detect possible metastatic or primary neoplastic lesions (known neoplastic antecedent), or for assessment and / or follow-up of known neoplastic bone lesions
* Patient agreeing to perform the additional 25 minutes of recording with the VERITON-CT ™ camera.
* Patient being affiliated to a social security scheme
Exclusion Criteria:
* A woman who is pregnant or of childbearing age and without suitable contraceptive means
* No signature of the informed consent form by the patient.
* Unstable medical condition and / or inability to remain still in the supine position during the recordings
* Person with a known allergy to one of the components of the radiotracer (TECHNESCAN HDP).
* Person deprived of liberty by a judicial or administrative decision.
* Major person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
* Major person unable to express consent.
Source: ClinicalTrials.gov (NCT04157166). StuddyBuddy aggregates publicly available trial information.